Test Price
2,800 AED✅ Home Collection Available
PLP1 Gene Pelizaeus-Merzbacher Disease Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 Certified Next Generation Sequencing (NGS) processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Complimentary post-test telephonic clinical interpretation by a DHA-licensed genetic counsellor.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test utilizes Next-Generation Sequencing (NGS) to analyze the entire coding region of the PLP1 gene, detecting pathogenic variants including point mutations, deletions, and duplications. Pelizaeus-Merzbacher disease (PMD) is an X-linked leukodystrophy; a definitive molecular diagnosis enables early intervention and family counselling.
| Feature | Our Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | NGS (Full gene deletion/duplication & SNV detection) | Sanger sequencing (targeted exons only) |
| Turnaround Time | 3–4 Weeks | 5–7 Weeks |
| Diagnostic Yield | >99.9% sensitivity for PLP1 variants (including large rearrangements) | ~70–80% for point mutations only |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I understand the profound impact of a genetic diagnosis. This NGS-based test provides definitive molecular evidence for Pelizaeus-Merzbacher disease, enabling early therapeutic strategies and informed family planning. However, genetic variants must be interpreted within the full clinical context; always discuss results with your managing neurologist."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory & Clinical Correlation
Do not discontinue any prescribed medication without consulting your doctor. Genetic test results must be correlated with clinical symptoms and medication response. A positive PLP1 variant does not replace clinical judgment; always integrate with neurological assessment.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active bleeding disorder or severe anaemia (Hb <7 g/dL) – must be stabilised before blood draw.
- Exclusion: Known allergy to latex or antiseptic agents (chlorhexidine) – alternative materials available.
- Emergency Red Flags: New‑onset seizures, loss of consciousness, severe headache with vomiting, or acute vision changes during the testing period – proceed directly to the nearest ER and inform the on‑call geneticist.
Patient FAQ & Clinical Guidance
1. What does the PLP1 NGS test detect, and how accurate is it?
This NGS-based test detects all classes of PLP1 variants (point mutations, deletions, duplications) with >99.9% analytical sensitivity, providing a definitive molecular diagnosis for Pelizaeus-Merzbacher disease. The test covers the entire coding region and intronic boundaries to ensure comprehensive variant detection.
2. How is the sample collected, and is a doctor’s referral required?
A DHA-licensed mobile phlebotomist performs a blood draw at your home within 24 hours of booking. A physician referral is mandatory and can be submitted via WhatsApp to +971 54 548 8731. The sample is transported under a temperature-controlled cold chain to our ISO 9001:2015 certified laboratory.
3. When will I receive my results, and who explains them?
Reports are issued within 3–4 weeks. A complimentary tele-consultation with a DHA-licensed genetic counsellor is automatically scheduled within 48 hours of report release to interpret the findings, discuss clinical implications, and guide next steps including family planning or specialist referrals.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Healthcare Compliance
This laboratory operates under DHA Facility License 1143. All patient data is processed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information is encrypted and accessible only to authorized healthcare professionals involved in your care.
Clinical & Logistical Metadata
| Test Name | PLP1 Gene Pelizaeus-Merzbacher Disease Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene deletion/duplication & SNV detection |
| ICD-10-CM Code | G37.0 |
| LOINC Code | 62138-2 |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians